Cargando…
The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women
The incidence of ovarian cancer depends on the ethnicity and geographical area. Menopausal status is a well-known risk factor for ovarian cancer and most cases occur after menopause in Caucasians. However, it is less clear how the status of menopause or age at diagnosis is associated with ovarian ca...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655222/ https://www.ncbi.nlm.nih.gov/pubmed/29113327 http://dx.doi.org/10.18632/oncotarget.20384 |
_version_ | 1783273490378391552 |
---|---|
author | Shen, Fang Chen, Shouzhen Gao, Yifei Dai, Xujing Chen, Qi |
author_facet | Shen, Fang Chen, Shouzhen Gao, Yifei Dai, Xujing Chen, Qi |
author_sort | Shen, Fang |
collection | PubMed |
description | The incidence of ovarian cancer depends on the ethnicity and geographical area. Menopausal status is a well-known risk factor for ovarian cancer and most cases occur after menopause in Caucasians. However, it is less clear how the status of menopause or age at diagnosis is associated with ovarian cancer including its subtypes in Chinese women. Data on 1,283 women with primary malignant or borderline ovarian cancer including age at diagnosis, age at menopause and histology from the largest women's hospital in China was analysed. The median age at diagnosis was 53, 44 and 23 years for epithelial ovarian cancer or sex-cord tumors or germ cell tumors respectively. 58% of epithelial ovarian cancers were diagnosed after menopause, while 58% and 95% of sex-cord tumors and germ cell tumors were diagnosed before menopause. Around 60% of serous, endometrioid and clear-cell carcinoma of epithelial ovarian cancer were diagnosed after menopause, while 23% of mucinous carcinoma was diagnosed after menopause. The median age at diagnosis was 35 years for borderline ovarian cancer and 80% of patients were diagnosed before menopause. Our data demonstrates that the median age at diagnosis of ovarian cancer is younger in our study population than Caucasians reported in the literature regardless of malignant or borderline ovarian cancers, and regardless of subtypes of epithelial ovarian cancer. The prevalence of ovarian cancer is proportionately higher in our study population before menopause than Caucasians. Our results suggest clinicians to be more aware of the symptoms of ovarian cancer in premenopausal Chinese women. |
format | Online Article Text |
id | pubmed-5655222 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56552222017-11-06 The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women Shen, Fang Chen, Shouzhen Gao, Yifei Dai, Xujing Chen, Qi Oncotarget Research Paper The incidence of ovarian cancer depends on the ethnicity and geographical area. Menopausal status is a well-known risk factor for ovarian cancer and most cases occur after menopause in Caucasians. However, it is less clear how the status of menopause or age at diagnosis is associated with ovarian cancer including its subtypes in Chinese women. Data on 1,283 women with primary malignant or borderline ovarian cancer including age at diagnosis, age at menopause and histology from the largest women's hospital in China was analysed. The median age at diagnosis was 53, 44 and 23 years for epithelial ovarian cancer or sex-cord tumors or germ cell tumors respectively. 58% of epithelial ovarian cancers were diagnosed after menopause, while 58% and 95% of sex-cord tumors and germ cell tumors were diagnosed before menopause. Around 60% of serous, endometrioid and clear-cell carcinoma of epithelial ovarian cancer were diagnosed after menopause, while 23% of mucinous carcinoma was diagnosed after menopause. The median age at diagnosis was 35 years for borderline ovarian cancer and 80% of patients were diagnosed before menopause. Our data demonstrates that the median age at diagnosis of ovarian cancer is younger in our study population than Caucasians reported in the literature regardless of malignant or borderline ovarian cancers, and regardless of subtypes of epithelial ovarian cancer. The prevalence of ovarian cancer is proportionately higher in our study population before menopause than Caucasians. Our results suggest clinicians to be more aware of the symptoms of ovarian cancer in premenopausal Chinese women. Impact Journals LLC 2017-08-22 /pmc/articles/PMC5655222/ /pubmed/29113327 http://dx.doi.org/10.18632/oncotarget.20384 Text en Copyright: © 2017 Shen et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Shen, Fang Chen, Shouzhen Gao, Yifei Dai, Xujing Chen, Qi The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women |
title | The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women |
title_full | The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women |
title_fullStr | The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women |
title_full_unstemmed | The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women |
title_short | The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women |
title_sort | prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal chinese women |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655222/ https://www.ncbi.nlm.nih.gov/pubmed/29113327 http://dx.doi.org/10.18632/oncotarget.20384 |
work_keys_str_mv | AT shenfang theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT chenshouzhen theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT gaoyifei theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT daixujing theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT chenqi theprevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT shenfang prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT chenshouzhen prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT gaoyifei prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT daixujing prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen AT chenqi prevalenceofmalignantandborderlineovariancancerinpreandpostmenopausalchinesewomen |